Sung Lee, EVP & Chief Financial Officer at Vir Biotechnology, Inc. (VIR), sold 12,016 shares at $9.89 ($119K) on 2024-03-27, disclosed to the SEC on 2024-03-28.
Open-market sale of $119k VIR by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.89 | 6,008 | $59K | 50.0% |
| 2 | $9.89 | 6,008 | $59K | 50.0% |
| Total | $9.89 avg | 12,016 | $119K | 100% |
| Filing → |
| CYTK | SELL | 2026-06-29 | $3.2M | — | Filing → |
| CYTK | SELL | 2026-05-05 | $1.8M | — | Filing → |
| CYTK | SELL | 2026-03-18 | $307K | — | Filing → |